1. Home
  2. THRY vs CGEN Comparison

THRY vs CGEN Comparison

Compare THRY & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thryv Holdings Inc.

THRY

Thryv Holdings Inc.

HOLD

Current Price

$2.61

Market Cap

128.1M

Sector

Industrials

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.12

Market Cap

148.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THRY
CGEN
Founded
2012
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
128.1M
148.7M
IPO Year
2020
2001

Fundamental Metrics

Financial Performance
Metric
THRY
CGEN
Price
$2.61
$2.12
Analyst Decision
Buy
Strong Buy
Analyst Count
4
1
Target Price
$9.33
$4.00
AVG Volume (30 Days)
1.7M
322.2K
Earning Date
04-30-2026
03-02-2026
Dividend Yield
N/A
N/A
EPS Growth
100.50
N/A
EPS
0.01
N/A
Revenue
$785,015,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$112.37
P/E Ratio
$283.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.91
$1.13
52 Week High
$15.60
$2.38

Technical Indicators

Market Signals
Indicator
THRY
CGEN
Relative Strength Index (RSI) 37.66 54.55
Support Level $1.91 $1.47
Resistance Level $3.69 $2.35
Average True Range (ATR) 0.26 0.10
MACD 0.04 -0.02
Stochastic Oscillator 15.56 34.86

Price Performance

Historical Comparison
THRY
CGEN

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.

Share on Social Networks: